Elewa H - Search Results

1

Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1.

Elgebaly MM, Kelly A, Harris AK, Elewa H, Portik-Dobos V, Ketsawatsomkron P, Marrero M, Ergul A. Elgebaly MM, et al. Among authors: elewa h. Can J Physiol Pharmacol. 2008 Jun;86(6):358-64. doi: 10.1139/Y08-034. Can J Physiol Pharmacol. 2008. PMID: 18516099 Free PMC article.

2

Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection.

Elewa HF, Kozak A, Johnson MH, Ergul A, Fagan SC. Elewa HF, et al. J Hypertens. 2007 Apr;25(4):855-9. doi: 10.1097/HJH.0b013e3280149708. J Hypertens. 2007. PMID: 17351379

3

Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes.

Ergul A, Elgebaly MM, Middlemore ML, Li W, Elewa H, Switzer JA, Hall C, Kozak A, Fagan SC. Ergul A, et al. Among authors: elewa h. BMC Neurol. 2007 Oct 15;7:33. doi: 10.1186/1471-2377-7-33. BMC Neurol. 2007. PMID: 17937795 Free PMC article.

4

Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke.

Kozak A, Ergul A, El-Remessy AB, Johnson MH, Machado LS, Elewa HF, Abdelsaid M, Wiley DC, Fagan SC. Kozak A, et al. Among authors: elewa hf. Stroke. 2009 May;40(5):1870-6. doi: 10.1161/STROKEAHA.108.537225. Epub 2009 Mar 5. Stroke. 2009. PMID: 19265050 Free PMC article.

5

Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats.

Elewa HF, Kozak A, El-Remessy AB, Frye RF, Johnson MH, Ergul A, Fagan SC. Elewa HF, et al. J Pharmacol Exp Ther. 2009 Aug;330(2):532-40. doi: 10.1124/jpet.108.146951. Epub 2009 May 28. J Pharmacol Exp Ther. 2009. PMID: 19478137 Free PMC article.

6

Diverse effects of statins on angiogenesis: new therapeutic avenues.

Elewa HF, El-Remessy AB, Somanath PR, Fagan SC. Elewa HF, et al. Pharmacotherapy. 2010 Feb;30(2):169-76. doi: 10.1592/phco.30.2.169. Pharmacotherapy. 2010. PMID: 20099991 Review.

7

Minocycline for short-term neuroprotection.

Elewa HF, Hilali H, Hess DC, Machado LS, Fagan SC. Elewa HF, et al. Pharmacotherapy. 2006 Apr;26(4):515-21. doi: 10.1592/phco.26.4.515. Pharmacotherapy. 2006. PMID: 16553511 Free PMC article. Review.

8

Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study.

Kozak W, Kozak A, Johnson MH, Elewa HF, Fagan SC. Kozak W, et al. Among authors: elewa hf. J Pharmacol Exp Ther. 2008 Sep;326(3):773-82. doi: 10.1124/jpet.108.139618. Epub 2008 Jun 17. J Pharmacol Exp Ther. 2008. PMID: 18559971

9

Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome.

Paravattil B, Elewa H. Paravattil B, et al. Among authors: elewa h. J Cardiovasc Pharmacol Ther. 2017 Jul;22(4):347-355. doi: 10.1177/1074248416683048. Epub 2016 Dec 21. J Cardiovasc Pharmacol Ther. 2017. PMID: 28587584 Review.

10

Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience.

Elewa H, El-Makaty H, Ali Z. Elewa H, et al. J Cardiovasc Pharmacol Ther. 2018 Mar;23(2):155-161. doi: 10.1177/1074248417731536. Epub 2017 Oct 4. J Cardiovasc Pharmacol Ther. 2018. PMID: 28978236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters